Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current therapy for autoimmune hepatitis.

Aldo J Montano Loza1, Albert J Czaja

  • 1Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

Nature Clinical Practice. Gastroenterology & Hepatology
|April 4, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Actin-specific smooth muscle antibodies bridge adult and juvenile autoimmune hepatitis diagnosis.

JHEP reports : innovation in hepatology·2026
Same author

Autoimmune Hepatitis Treatment: Can Low-Dose Steroids Be Generalized?

Digestive diseases and sciences·2025
Same author

Cellular senescence and its pathogenic and therapeutic implications in autoimmune hepatitis.

Expert review of gastroenterology & hepatology·2024
Same author

Easy recognition and high autoimmune hepatitis specificity of smooth muscle antibodies giving an actin microfilament immunofluorescent pattern on embryonal vascular smooth muscle cells.

Clinical and experimental immunology·2024
Same author

Introducing Molecular Chaperones into the Causality and Prospective Management of Autoimmune Hepatitis.

Digestive diseases and sciences·2023
Same author

Prevalence and significance of antimitochondrial antibodies in autoimmune hepatitis (AIH): Results from a large multicentre study of the International AIH Group.

European journal of internal medicine·2023
Same journal

Proteomic and metabolic prediction of response to therapy in gastrointestinal cancers.

Nature clinical practice. Gastroenterology & hepatology·2009
Same journal

A perfect storm.

Nature clinical practice. Gastroenterology & hepatology·2009
Same journal

Gastric electric stimulation is a viable option in gastroparesis treatment.

Nature clinical practice. Gastroenterology & hepatology·2009
Same journal

Misconception of treatment for liver disease unique to pregnancy.

Nature clinical practice. Gastroenterology & hepatology·2009
Same journal

Probiotic prophylaxis in acute pancreatitis: prudence required.

Nature clinical practice. Gastroenterology & hepatology·2009
Same journal

Duration of treatment with albendazole for hepatic toxocariasis.

Nature clinical practice. Gastroenterology & hepatology·2009
See all related articles

Current autoimmune hepatitis treatments include prednisone and azathioprine. Emerging therapies and understanding of genetic factors like HLA genotypes offer evolving strategies for better patient outcomes and managing treatment resistance.

Area of Science:

  • Hepatology
  • Immunology
  • Pharmacology

Background:

  • Autoimmune hepatitis (AIH) treatment is advancing with better understanding of disease mechanisms.
  • Conventional therapy involves prednisone and azathioprine, but patient response varies.
  • Genetic factors, such as HLA genotype DRB1*0301, influence treatment outcomes.

Purpose of the Study:

  • To review current and evolving treatment strategies for autoimmune hepatitis.
  • To highlight the impact of genetic factors on treatment response.
  • To discuss novel therapeutic approaches and future directions.

Main Methods:

  • Review of current literature on autoimmune hepatitis treatment.
  • Analysis of conventional immunosuppressive therapies.

Related Experiment Videos

  • Exploration of emerging and experimental treatment modalities.

    • Main Results:

    • Prednisone and azathioprine remain standard, with varying efficacy.
    • HLA genotype DRB1*0301 is associated with poorer response and increased need for transplantation.
    • Alternative agents like ciclosporin, calcineurin inhibitors, mycophenolate mofetil, and sirolimus show promise in specific contexts.
    • Relapse can occur even with normalized liver tests and histology.

    Conclusions:

    • Autoimmune hepatitis treatment is dynamic, influenced by pathogenic pathways and genetic predispositions.
    • While conventional therapies are effective, treatment failure necessitates diagnostic reassessment.
    • Future interventions may include targeted molecular therapies, cytokine manipulation, and gene therapy, pending further research.